DiscoverOmnivoreEP 55: Rethinking Approaches to Obesity, Precision Fermentation Takes Off, GLP-1 Drugs: A Boon for Product Development
EP 55: Rethinking Approaches to Obesity, Precision Fermentation Takes Off, GLP-1 Drugs: A Boon for Product Development

EP 55: Rethinking Approaches to Obesity, Precision Fermentation Takes Off, GLP-1 Drugs: A Boon for Product Development

Update: 2025-03-03
Share

Description

Obesity policy expert Ted Kyle shares his thoughts on how the food industry should respond to consumers’ need for more healthful food options, and why he’s not a fan of the food as medicine concept. Process engineer Shalima Sreenath, whose previous work with Beyond Meat focused on scaling up transformative alt-meat technologies, shares the exciting new possibilities of precision fermentation technology in the food and ag space. With anti-obesity drugs on the rise, Barb Stuckey, chief new product strategy officer at Mattson, talks about the abundant innovation opportunities for companies.


Plus: This episode of Omnivore is brought to you by IFT Virtual Workshops, where you stay “in the know” instead of “on the go.” Learn more about all four exciting new virtual workshops on the Career Development page at ift.org

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

EP 55: Rethinking Approaches to Obesity, Precision Fermentation Takes Off, GLP-1 Drugs: A Boon for Product Development

EP 55: Rethinking Approaches to Obesity, Precision Fermentation Takes Off, GLP-1 Drugs: A Boon for Product Development